Skip to main content
Professional Technical IVT

arrhythmogenic right ventricular cardiomyopathy

Also written as: ARVC — Arrhythmogenic Right Ventricular Cardiomyopathy

A hereditary cardiomyopathy characterized by fibrofatty replacement of right ventricular myocardium, predisposing to ventricular arrhythmias.

Full Definition

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by progressive fibrofatty replacement of the right ventricular myocardium. This structural abnormality creates a substrate for ventricular arrhythmias, particularly in young athletes. The condition is associated with sudden cardiac death and requires careful evaluation with imaging, genetic testing, and electrophysiologic assessment. Treatment often involves activity restriction, antiarrhythmic medications, and implantable cardioverter-defibrillator placement.

Usage

Usage note: Often abbreviated as ARVC; previously known as ARVD (arrhythmogenic right ventricular dysplasia).

In Context

  • "The patient's family history of sudden cardiac death and epsilon waves on ECG raised suspicion for arrhythmogenic right ventricular cardiomyopathy." — Clinical case report
  • "Cardiac MRI revealed right ventricular wall motion abnormalities consistent with ARVC." — Imaging study interpretation

Also known as

ARVC arrhythmogenic right ventricular dysplasia ARVD

Don't confuse with

dilated cardiomyopathy hypertrophic cardiomyopathy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON